Michael Potter
Affiliations: | University of Maryland, College Park, College Park, MD |
Area:
Cell Biology, Microbiology Biology, ImmunologyGoogle:
"Michael Potter"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Casellas R, Yamane A, Kovalchuk AL, et al. (2009) Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes. Immunology. 126: 316-28 |
Potter M. (2008) Brief historical sketch of chromosomal translocations and tumors. Journal of the National Cancer Institute. Monographs. 2-7 |
Potter M. (2007) The early history of plasma cell tumors in mice, 1954-1976. Advances in Cancer Research. 98: 17-51 |
Park SS, Shaffer AL, Kim JS, et al. (2005) Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice. Cancer Research. 65: 7644-52 |
McAllister RD, Singh Y, du Bois WD, et al. (2003) Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci. The American Journal of Pathology. 163: 1735-41 |
Potter M. (2003) Neoplastic development in plasma cells. Immunological Reviews. 194: 177-195 |
NATHANS D, FAHEY JL, POTTER M. (2000) The formation of myeloma protein by a mouse plasma cell tumor. The Journal of Experimental Medicine. 108: 121-30 |
Potter M. (1999) Indomethacin Inhibition of Pristane Plasmacytomagenesis in Genetically Susceptible Inbred Mice Advances in Experimental Medicine and Biology. 469: 151-156 |
Potter M, Kutkat L. (1999) Inhibition of pristane-induced peritoneal plasmacytoma formation. Current Topics in Microbiology and Immunology. 246: 351-362 |
Potter M, Wax JS, Hansen CT, et al. (1999) BALB/c.CBA/N mice carrying the defective Btkxid gene are resistant to pristane-induced plasmacytomagenesis International Immunology. 11: 1059-1064 |